Origen Therapeutics

Develops human polyclonal antibodies from avian transgenic animal technology

placeBurlingame, California, United States calendar_todayFounded 1997 language origentherapeutics.com

Innovation

9 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 208 times.

YearFilings
20122
20131
20142
20161

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%
Coming soon